Previously Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer research hub

A Double-Blind, Randomized, Active-Controlled, Parallel-Group, Phase 3 Study to Compare Efficacy and Safety of CT-P51 and Keytruda in Combination with Platinum-Pemetrexed Chemotherapy in Patients with Previously Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer

This study tests a new medicine called CT-P51 compared to an established treatment, Keytruda, for advanced non-small cell lung cancer. Both medicines are given with standard chemotherapy. The aim is to see if CT-P51 works just as well and is just as safe as Keytruda for newly diagnosed patients.